speb/financial-data huggingface dataset:
CVSA cash_flow (annual, 2024-06-30) — Operating Gains Losses: -252000.00
CVSA income_statement (annual, 2024-06-30) — Operating Income: 253139000.00
CVSA income_statement (annual, 2024-06-30) — Operating Revenue: 1571243000.00
CVSA balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 37681000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Current Assets: 70050000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: -2227000.00
CVSA income_statement (annual, 2024-06-30) — Other Income Expense: -34720000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 776694000.00
CVSA cash_flow (annual, 2024-06-30) — Other Non Cash Items: 5663000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 111009000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Non Current Liabilities: 38675000.00
CVSA income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 10542000.00
CVSA balance_sheet (annual, 2024-06-30) — Other Properties: 176755000.00
CVSA balance_sheet (annual, 2024-06-30) — Payables: 102626000.00
CVSA balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 270956000.00
CVSA income_statement (annual, 2024-06-30) — Pretax Income: 163937000.00
CVSA cash_flow (annual, 2024-06-30) — Proceeds From Stock Option Exercised: 17899000.00
CVSA balance_sheet (annual, 2024-06-30) — Properties: 0.00
CVSA cash_flow (annual, 2024-06-30) — Provisionand Write Offof Assets: 53175000.00
CVSA cash_flow (annual, 2024-06-30) — Purchase Of Business: 0.00
CVSA cash_flow (annual, 2024-06-30) — Purchase Of Investment: -689000.00
CVSA balance_sheet (annual, 2024-06-30) — Receivables: 126833000.00
CVSA income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 698548000.00
CVSA income_statement (annual, 2024-06-30) — Reconciled Depreciation: 107961000.00
CVSA cash_flow (annual, 2024-06-30) — Repayment Of Debt: -51896000.00
CVSA cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -261966000.00
CVSA balance_sheet (annual, 2024-06-30) — Restricted Cash: 1896000.00
CVSA income_statement (annual, 2024-06-30) — Restructuring And Mergern Acquisition: 36085000.00
CVSA balance_sheet (annual, 2024-06-30) — Retained Earnings: 2540509000.00
CVSA cash_flow (annual, 2024-06-30) — Sale Of Investment: 1732000.00
CVSA income_statement (annual, 2024-06-30) — Selling General And Administration: 632965000.00
CVSA balance_sheet (annual, 2024-06-30) — Share Issued: 83194000.00
CVSA income_statement (annual, 2024-06-30) — Special Income Charges: -36085000.00
CVSA cash_flow (annual, 2024-06-30) — Stock Based Compensation: 25947000.00
CVSA balance_sheet (annual, 2024-06-30) — Stockholders Equity: 1369135000.00
CVSA balance_sheet (annual, 2024-06-30) — Tangible Book Value: -368821000.00
CVSA income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: -5555200.00
CVSA income_statement (annual, 2024-06-30) — Tax Provision: 26224000.00
CVSA income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.16
CVSA balance_sheet (annual, 2024-06-30) — Total Assets: 2741417000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Capitalization: 2017847000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Debt: 847853000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 1369135000.00
CVSA income_statement (annual, 2024-06-30) — Total Expenses: 1331513000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1372282000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 2323332000.00
CVSA balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 884625000.00
CVSA income_statement (annual, 2024-06-30) — Total Operating Income As Reported: 217054000.00
CVSA income_statement (annual, 2024-06-30) — Total Other Finance Cost: 9400000.00
CVSA income_statement (annual, 2024-06-30) — Total Unusual Items: -34720000.00
CVSA income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -34720000.00
CVSA balance_sheet (annual, 2024-06-30) — Treasury Shares Number: 45513000.00
CVSA balance_sheet (annual, 2024-06-30) — Treasury Stock: 1781928000.00
CVSA balance_sheet (annual, 2024-06-30) — Working Capital: -69572000.00
CVSA cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: -7888000.00
CVSA cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: -56803000.00
CVSA income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 159073000.00
CVSA income_statement (quarterly, 2024-09-30) — Other Gand A: 159073000.00
CVSA balance_sheet (quarterly, 2024-09-30) — Other Receivables: 2590000.00
CVSA cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -6183000.00
CVSA cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 10310000.00
CVSA balance_sheet (quarterly, 2024-12-31) — Other Receivables: 2622000.00
CVSA income_statement (quarterly, 2025-03-31) — +Operating Expense: 175167000.00
CVSA income_statement (quarterly, 2025-03-31) — +Total Revenue: 466055000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 98709000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 160358000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -332197000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 653635000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -44183000.00
CVSA cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 2805000.00
CVSA cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 2805000.00
CVSA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 37140000.00
CVSA income_statement (quarterly, 2025-03-31) — Basic EPS: 1.64
CVSA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 195419000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 202150000.00
CVSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -10243000.00
CVSA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -10243000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 228342000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 839000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 219017000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 219017000.00
CVSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -172099000.00
CVSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -10049000.00
CVSA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 207856000.00
CVSA cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 54000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 24610000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 40334000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -7245000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 55970000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Payable: 24610000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 64944000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1102000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -34120000.00
CVSA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 92518000.00
CVSA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -34120000.00
CVSA cash_flow (quarterly, 2025-03-31) — Changes In Cash: 25762000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Common Stock: 839000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1432713000.00
CVSA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -72370000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 20625000.00
CVSA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 199869000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 159167000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Assets: 450343000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 34882000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 34882000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 247811000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 247811000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 540569000.00
CVSA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -3522000.00
CVSA cash_flow (quarterly, 2025-03-31) — Deferred Tax: -3522000.00
CVSA cash_flow (quarterly, 2025-03-31) — Depreciation: 21512000.00
CVSA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 24317000.00
CVSA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 24317000.00
CVSA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 38233000.00
CVSA income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.59
CVSA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 60832000.00
CVSA income_statement (quarterly, 2025-03-31) — EBIT: 90701000.00
CVSA income_statement (quarterly, 2025-03-31) — EBITDA: 115018000.00
CVSA cash_flow (quarterly, 2025-03-31) — End Cash Position: 221181000.00
CVSA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -172099000.00
CVSA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 197667000.00
CVSA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 174000.00
CVSA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 2408000.00
CVSA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -174000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 175167000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Goodwill: 961262000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1729541000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 204541000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 781426000.00
CVSA income_statement (quarterly, 2025-03-31) — Gross Profit: 266186000.00
CVSA income_statement (quarterly, 2025-03-31) — Interest Expense: 11368000.00
CVSA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 11368000.00
CVSA income_statement (quarterly, 2025-03-31) — Interest Income: 2072000.00
CVSA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2072000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1984899000.00
CVSA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -10049000.00
CVSA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CVSA balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 31776000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Leases: 116375000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 193460000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 552186000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 745646000.00
CVSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CVSA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -100000000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 212035000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -72370000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Net Debt: 333169000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income: 60832000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 60832000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 60794000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 38000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 60832000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 60794000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 60794000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 60832000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Interest Income: -11002000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 194000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -100000000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -100000000.00
CVSA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -11002000.00
CVSA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -259000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Net PPE: 449229000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -296828000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 33157000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 33589000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 33157000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 33589000.00
CVSA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 115702000.00
CVSA income_statement (quarterly, 2025-03-31) — Normalized Income: 61318158.87
CVSA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 207910000.00
CVSA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2582000.00
CVSA income_statement (quarterly, 2025-03-31) — Operating Income: 91019000.00
CVSA income_statement (quarterly, 2025-03-31) — Operating Revenue: 463607000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 36512000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 66190000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2227000.00
CVSA income_statement (quarterly, 2025-03-31) — Other Gand A: 175167000.00
CVSA income_statement (quarterly, 2025-03-31) — Other Income Expense: -684000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 768279000.00
CVSA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2769000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 127489000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 37242000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Properties: 198465000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2614000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Payables: 98709000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 257876000.00
CVSA income_statement (quarterly, 2025-03-31) — Pretax Income: 79333000.00
CVSA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 530000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CVSA cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 18135000.00
CVSA cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CVSA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -500000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Receivables: 162972000.00
CVSA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 199869000.00
CVSA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 24317000.00
CVSA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -100000000.00
CVSA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -72370000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 2164000.00
CVSA income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 510000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2723362000.00
CVSA cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 694000.00
CVSA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 175167000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Share Issued: 83899000.00
CVSA income_statement (quarterly, 2025-03-31) — Special Income Charges: -510000.00
CVSA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10263000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1432713000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -296828000.00
CVSA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -159841.13
CVSA income_statement (quarterly, 2025-03-31) — Tax Provision: 18539000.00
CVSA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
CVSA balance_sheet (quarterly, 2025-03-31) — Total Assets: 2789759000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1984899000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Debt: 780528000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1432713000.00
CVSA income_statement (quarterly, 2025-03-31) — Total Expenses: 375036000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1357046000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2339416000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 816477000.00
CVSA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 90509000.00
CVSA income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 1706000.00
CVSA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -684000.00
CVSA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -684000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 47387000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 1942896000.00
CVSA balance_sheet (quarterly, 2025-03-31) — Working Capital: -90226000.00
CVSA income_statement (annual, 2025-06-30) — +Operating Expense: 672004000.00
CVSA income_statement (quarterly, 2025-06-30) — +Operating Expense: 180863000.00
CVSA income_statement (annual, 2025-06-30) — +Total Revenue: 1788290000.00
CVSA income_statement (quarterly, 2025-06-30) — +Total Revenue: 457106000.00
CVSA balance_sheet (annual, 2025-06-30) — Accounts Payable: 105017000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 105017000.00
CVSA balance_sheet (annual, 2025-06-30) — Accounts Receivable: 146189000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 146189000.00
CVSA balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -341744000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -341744000.00
CVSA balance_sheet (annual, 2025-06-30) — Additional Paid In Capital: 664300000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 664300000.00
CVSA balance_sheet (annual, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -49078000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -49078000.00
CVSA cash_flow (annual, 2025-06-30) — Amortization Cash Flow: 11220000.00
CVSA cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 2805000.00
CVSA cash_flow (annual, 2025-06-30) — Amortization Of Intangibles: 11220000.00
CVSA cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 2805000.00
CVSA income_statement (annual, 2025-06-30) — Basic Average Shares: 37085000.00
CVSA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 36034000.00
CVSA income_statement (annual, 2025-06-30) — Basic EPS: 6.39
CVSA income_statement (quarterly, 2025-06-30) — Basic EPS: 1.50
CVSA cash_flow (annual, 2025-06-30) — Beginning Cash Position: 221202000.00
CVSA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 221181000.00
CVSA balance_sheet (annual, 2025-06-30) — Buildings And Improvements: 202240000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 202240000.00
CVSA cash_flow (annual, 2025-06-30) — Capital Expenditure: -50327000.00
CVSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -18990000.00
CVSA cash_flow (annual, 2025-06-30) — Capital Expenditure Reported: -50327000.00
CVSA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -18990000.00
CVSA balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 221331000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 221331000.00
CVSA balance_sheet (annual, 2025-06-30) — Capital Stock: 839000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 839000.00
CVSA balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 199601000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 199601000.00
CVSA balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 199601000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 199601000.00
CVSA cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: -316016000.00
CVSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -68053000.00
CVSA cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -41921000.00
CVSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -11656000.00
CVSA cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Operating Activities: 333734000.00
CVSA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 59921000.00
CVSA cash_flow (annual, 2025-06-30) — Cash From Discontinued Investing Activities: 0.00
CVSA cash_flow (annual, 2025-06-30) — Cash From Discontinued Operating Activities: 4165000.00
CVSA cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: -229000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Account Payable: 140000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 10118000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Accrued Expense: -10804000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1761000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Other Current Assets: -32823000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Other Current Liabilities: -24792000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -6953000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Other Working Capital: 28977000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -9077000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Payable: 140000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Payable: 10118000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Payables And Accrued Expense: -10664000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 8357000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Prepaid Assets: 5546000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -181000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Receivables: -80820000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -207000.00
CVSA cash_flow (annual, 2025-06-30) — Change In Working Capital: -114576000.00
CVSA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -40884000.00
CVSA cash_flow (annual, 2025-06-30) — Changes In Cash: -20038000.00
CVSA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -20017000.00
CVSA balance_sheet (annual, 2025-06-30) — Common Stock: 839000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Common Stock: 839000.00
CVSA balance_sheet (annual, 2025-06-30) — Common Stock Equity: 1433625000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1433625000.00
CVSA cash_flow (annual, 2025-06-30) — Common Stock Payments: -213125000.00
CVSA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -66689000.00
CVSA balance_sheet (annual, 2025-06-30) — Construction In Progress: 24983000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 24983000.00
CVSA income_statement (annual, 2025-06-30) — Cost Of Revenue: 771430000.00
CVSA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 198930000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Accrued Expenses: 153660000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 153660000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Assets: 416190000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Assets: 416190000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Capital Lease Obligation: 35159000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 35159000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 35159000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 35159000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 214091000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 214091000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Deferred Revenue: 214091000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 214091000.00
CVSA balance_sheet (annual, 2025-06-30) — Current Liabilities: 507927000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 507927000.00
CVSA cash_flow (annual, 2025-06-30) — Deferred Income Tax: 18413000.00
CVSA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1581000.00
CVSA cash_flow (annual, 2025-06-30) — Deferred Tax: 18413000.00
CVSA cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1581000.00
CVSA cash_flow (annual, 2025-06-30) — Depreciation: 73245000.00
CVSA cash_flow (quarterly, 2025-06-30) — Depreciation: 17648000.00
CVSA cash_flow (annual, 2025-06-30) — Depreciation Amortization Depletion: 84465000.00
CVSA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 20453000.00
CVSA cash_flow (annual, 2025-06-30) — Depreciation And Amortization: 84465000.00
CVSA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 20453000.00
CVSA income_statement (annual, 2025-06-30) — Diluted Average Shares: 38334000.00
CVSA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 37584000.00
CVSA income_statement (annual, 2025-06-30) — Diluted EPS: 6.18
CVSA income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.44
CVSA income_statement (annual, 2025-06-30) — Diluted NI Availto Com Stockholders: 237065000.00
CVSA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 54212000.00
CVSA income_statement (annual, 2025-06-30) — EBIT: 342845000.00
CVSA income_statement (quarterly, 2025-06-30) — EBIT: 77882000.00
CVSA income_statement (annual, 2025-06-30) — EBITDA: 427310000.00
CVSA income_statement (quarterly, 2025-06-30) — EBITDA: 98335000.00
CVSA cash_flow (annual, 2025-06-30) — End Cash Position: 201164000.00
CVSA cash_flow (quarterly, 2025-06-30) — End Cash Position: 201164000.00
CVSA cash_flow (annual, 2025-06-30) — Financing Cash Flow: -316016000.00
CVSA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -68053000.00
CVSA cash_flow (annual, 2025-06-30) — Free Cash Flow: 287572000.00
CVSA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 40702000.00
CVSA cash_flow (annual, 2025-06-30) — Gain Loss On Investment Securities: -1074000.00
CVSA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -806000.00
CVSA cash_flow (annual, 2025-06-30) — Gain Loss On Sale Of PPE: 2527000.00
CVSA cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 5000.00
CVSA income_statement (annual, 2025-06-30) — Gain On Sale Of Ppe: 0.00
CVSA income_statement (annual, 2025-06-30) — Gain On Sale Of Security: 1074000.00
CVSA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 806000.00
CVSA balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (annual, 2025-06-30) — Goodwill: 961262000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Goodwill: 961262000.00
CVSA balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 1726736000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1726736000.00
CVSA balance_sheet (annual, 2025-06-30) — Gross Accounts Receivable: 195267000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 195267000.00
CVSA balance_sheet (annual, 2025-06-30) — Gross PPE: 789069000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 789069000.00
CVSA income_statement (annual, 2025-06-30) — Gross Profit: 1016860000.00
CVSA income_statement (quarterly, 2025-06-30) — Gross Profit: 258176000.00
CVSA cash_flow (annual, 2025-06-30) — Income Tax Paid Supplemental Data: 32777000.00
CVSA income_statement (annual, 2025-06-30) — Interest Expense: 44331000.00
CVSA income_statement (quarterly, 2025-06-30) — Interest Expense: 9299000.00
CVSA income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 44331000.00
CVSA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 9299000.00
CVSA income_statement (annual, 2025-06-30) — Interest Income: 8216000.00
CVSA income_statement (quarterly, 2025-06-30) — Interest Income: 1705000.00
CVSA income_statement (annual, 2025-06-30) — Interest Income Non Operating: 8216000.00
CVSA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1705000.00
CVSA cash_flow (annual, 2025-06-30) — Interest Paid Supplemental Data: 46596000.00
CVSA balance_sheet (annual, 2025-06-30) — Invested Capital: 1986294000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1986294000.00
CVSA cash_flow (annual, 2025-06-30) — Investing Cash Flow: -41921000.00
CVSA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -11656000.00
CVSA cash_flow (annual, 2025-06-30) — Issuance Of Debt: 9873000.00
CVSA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CVSA balance_sheet (annual, 2025-06-30) — Land And Improvements: 31776000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 31776000.00
CVSA balance_sheet (annual, 2025-06-30) — Leases: 120603000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Leases: 120603000.00
CVSA balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 186172000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 186172000.00
CVSA balance_sheet (annual, 2025-06-30) — Long Term Debt: 552669000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 552669000.00
CVSA balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 738841000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 738841000.00
CVSA cash_flow (annual, 2025-06-30) — Long Term Debt Issuance: 9873000.00
CVSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CVSA cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -109873000.00
CVSA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
CVSA balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 218273000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 218273000.00
CVSA cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: -213125000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -66689000.00
CVSA balance_sheet (annual, 2025-06-30) — Net Debt: 353068000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Net Debt: 353068000.00
CVSA income_statement (annual, 2025-06-30) — Net Income: 237065000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income: 54212000.00
CVSA income_statement (annual, 2025-06-30) — Net Income Common Stockholders: 237065000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 54212000.00
CVSA income_statement (annual, 2025-06-30) — Net Income Continuous Operations: 232677000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 54462000.00
CVSA income_statement (annual, 2025-06-30) — Net Income Discontinuous Operations: 4388000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -250000.00
CVSA income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 237065000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 54212000.00
CVSA income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 232677000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 54462000.00
CVSA cash_flow (annual, 2025-06-30) — Net Income From Continuing Operations: 232677000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 54462000.00
CVSA income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: 237065000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 54212000.00
CVSA income_statement (annual, 2025-06-30) — Net Interest Income: -44102000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Interest Income: -9148000.00
CVSA cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: 1072000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CVSA cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -100000000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CVSA cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -100000000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CVSA income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: -44102000.00
CVSA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -9148000.00
CVSA cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -14200000.00
CVSA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1743000.00
CVSA cash_flow (annual, 2025-06-30) — Net Other Investing Changes: 7334000.00
CVSA balance_sheet (annual, 2025-06-30) — Net PPE: 447325000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Net PPE: 447325000.00
CVSA balance_sheet (annual, 2025-06-30) — Net Tangible Assets: -293111000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -293111000.00
CVSA balance_sheet (annual, 2025-06-30) — Non Current Deferred Assets: 32956000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 32956000.00
CVSA balance_sheet (annual, 2025-06-30) — Non Current Deferred Liabilities: 31856000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 31856000.00
CVSA balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Assets: 32956000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 32956000.00
CVSA balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Liabilities: 31856000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 31856000.00
CVSA income_statement (annual, 2025-06-30) — Normalized EBITDA: 429550000.00
CVSA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 97917000.00
CVSA income_statement (annual, 2025-06-30) — Normalized Income: 234421960.00
CVSA income_statement (quarterly, 2025-06-30) — Normalized Income: 54130064.74
CVSA cash_flow (annual, 2025-06-30) — Operating Cash Flow: 337899000.00
CVSA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 59692000.00
CVSA cash_flow (annual, 2025-06-30) — Operating Gains Losses: 1943000.00
CVSA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -311000.00
CVSA income_statement (annual, 2025-06-30) — Operating Income: 344856000.00
CVSA income_statement (quarterly, 2025-06-30) — Operating Income: 77313000.00
CVSA income_statement (annual, 2025-06-30) — Operating Revenue: 1778417000.00
CVSA income_statement (quarterly, 2025-06-30) — Operating Revenue: 455067000.00
CVSA balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 35952000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 35952000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Current Assets: 68837000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 68837000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: -2227000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2227000.00
CVSA income_statement (annual, 2025-06-30) — Other Income Expense: -2240000.00
CVSA income_statement (quarterly, 2025-06-30) — Other Income Expense: 418000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 765474000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 765474000.00
CVSA cash_flow (annual, 2025-06-30) — Other Non Cash Items: 5985000.00
CVSA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 990000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Non Current Assets: 129145000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 129145000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Non Current Liabilities: 40103000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 40103000.00
CVSA balance_sheet (annual, 2025-06-30) — Other Properties: 191194000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Other Properties: 191194000.00
CVSA balance_sheet (annual, 2025-06-30) — Payables: 105017000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Payables: 105017000.00
CVSA balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 258677000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 258677000.00
CVSA income_statement (annual, 2025-06-30) — Pretax Income: 298514000.00
CVSA income_statement (quarterly, 2025-06-30) — Pretax Income: 68583000.00
CVSA cash_flow (annual, 2025-06-30) — Proceeds From Stock Option Exercised: 11309000.00
CVSA cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 379000.00
CVSA balance_sheet (annual, 2025-06-30) — Properties: 0.00
CVSA balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CVSA cash_flow (annual, 2025-06-30) — Provisionand Write Offof Assets: 63237000.00
CVSA cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 16383000.00
CVSA cash_flow (annual, 2025-06-30) — Purchase Of Investment: -2048000.00
CVSA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CVSA balance_sheet (annual, 2025-06-30) — Receivables: 146189000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Receivables: 146189000.00
CVSA income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 771430000.00
CVSA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 198930000.00
CVSA income_statement (annual, 2025-06-30) — Reconciled Depreciation: 84465000.00
CVSA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 20453000.00
CVSA cash_flow (annual, 2025-06-30) — Repayment Of Debt: -109873000.00
CVSA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
CVSA cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -213125000.00
CVSA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -66689000.00
CVSA balance_sheet (annual, 2025-06-30) — Restricted Cash: 1563000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1563000.00
CVSA income_statement (annual, 2025-06-30) — Restructuring And Mergern Acquisition: 3314000.00
CVSA income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 388000.00
CVSA balance_sheet (annual, 2025-06-30) — Retained Earnings: 2777574000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2777574000.00
CVSA cash_flow (annual, 2025-06-30) — Sale Of Investment: 3120000.00
CVSA cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CVSA income_statement (annual, 2025-06-30) — Selling General And Administration: 672004000.00
CVSA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 180863000.00
CVSA balance_sheet (annual, 2025-06-30) — Share Issued: 83942000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Share Issued: 83942000.00
CVSA income_statement (annual, 2025-06-30) — Special Income Charges: -3314000.00
CVSA income_statement (quarterly, 2025-06-30) — Special Income Charges: -388000.00
CVSA cash_flow (annual, 2025-06-30) — Stock Based Compensation: 41590000.00
CVSA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 10409000.00
CVSA balance_sheet (annual, 2025-06-30) — Stockholders Equity: 1433625000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1433625000.00
CVSA balance_sheet (annual, 2025-06-30) — Tangible Book Value: -293111000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -293111000.00
CVSA income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: -495040.00
CVSA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 86064.74
CVSA income_statement (annual, 2025-06-30) — Tax Provision: 65837000.00
CVSA income_statement (quarterly, 2025-06-30) — Tax Provision: 14121000.00
CVSA income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.22
CVSA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CVSA balance_sheet (annual, 2025-06-30) — Total Assets: 2752352000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Assets: 2752352000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Capitalization: 1986294000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1986294000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Debt: 774000000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Debt: 774000000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 1433625000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1433625000.00
CVSA income_statement (annual, 2025-06-30) — Total Expenses: 1443434000.00
CVSA income_statement (quarterly, 2025-06-30) — Total Expenses: 379793000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 1318727000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1318727000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 2336162000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2336162000.00
CVSA balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 810800000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 810800000.00
CVSA income_statement (annual, 2025-06-30) — Total Operating Income As Reported: 341542000.00
CVSA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 76925000.00
CVSA income_statement (annual, 2025-06-30) — Total Other Finance Cost: 7987000.00
CVSA income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 1554000.00
CVSA income_statement (annual, 2025-06-30) — Total Unusual Items: -2240000.00
CVSA income_statement (quarterly, 2025-06-30) — Total Unusual Items: 418000.00
CVSA income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2240000.00
CVSA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 418000.00
CVSA balance_sheet (annual, 2025-06-30) — Treasury Shares Number: 47990000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 47990000.00
CVSA balance_sheet (annual, 2025-06-30) — Treasury Stock: 2006861000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2006861000.00
CVSA balance_sheet (annual, 2025-06-30) — Working Capital: -91737000.00
CVSA balance_sheet (quarterly, 2025-06-30) — Working Capital: -91737000.00
CVSA income_statement (quarterly, 2025-09-30) — +Operating Expense: 175734000.00
CVSA income_statement (quarterly, 2025-09-30) — +Total Revenue: 462288000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 104576000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 194837000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -350793000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 673022000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -54621000.00
CVSA cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 2805000.00
CVSA cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 2805000.00
CVSA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 36111000.00
CVSA income_statement (quarterly, 2025-09-30) — Basic EPS: 1.71
CVSA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 201164000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 203234000.00
CVSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16023000.00
CVSA cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -16023000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 222798000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 847000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 264691000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 264691000.00
CVSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -49505000.00
CVSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -16023000.00
CVSA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 130629000.00
CVSA cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: -80000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1378000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -36646000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -4812000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -4317000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 108122000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Payable: 1378000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -35268000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -29841000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -62690000.00
CVSA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -28806000.00
CVSA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 65021000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Common Stock: 847000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1457624000.00
CVSA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -7595000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 28656000.00
CVSA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 200767000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 114781000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Assets: 567217000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 34392000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 34392000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 322867000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 322867000.00
CVSA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 576616000.00
CVSA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 54413000.00
CVSA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 54413000.00
CVSA cash_flow (quarterly, 2025-09-30) — Depreciation: 17512000.00
CVSA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 20317000.00
CVSA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 20317000.00